HealthPhoto: Deccan HeraldSupreme Court Questions Centre on Capping Trade Margin of Anti-Cancer Drugs
The Supreme Court criticized the Centre's decision to cap the trade margin of anti-cancer drugs at 30% of the maximum retail price (MRP), questioning why similar caps are not applied to other medicines. The government expects this cap to save patients around Rs 2,500 crore annually. The court highlighted issues like a saline drip costing Rs 11 being sold for Rs 270, calling the response insufficient for patient benefit.
Deccan Herald··New Delhi



